Transmolecular Inc Headquarters
Looking for information about Transmolecular Inc Headquarters? The links below have collected all the necessary data.
TransMolecular - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/transmolecular
- TransMolecular's corporate offices and R&D laboratories are in Birmingham, Alabama. TransMolecular has received three Small Business Incentive Research (SBIR) grants totaling $1 million from the National Institutes of Health for its cancer and pain programs.Founded: Jul 01, 2007
TransMolecular Inc. - Company Profile - BCIQ
- https://www.biocentury.com/companies/transmolecular_inc
- Apr 16, 2017 · ...TransMolecular moved its headquarters to Cambridge, Mass., from Birmingham, Ala. TransMolecular Inc., Cambridge, Mass. Business: Cancer...
Transmolecular (Tumor Targeting Platform) Company Profile ...
- https://pitchbook.com/profiles/company/53721-91
- Transmolecular (Tumor Targeting Platform) General Information Description. Provider of a tumor targeting peptide (TTP) platform. The company helps deliver active TTP conjugates directly to tumor cells via systemic administration of radionucleotides, chemotoxins, nanoparticles and optical dyes, which enables optical imaging to confirm therapeutic effects.
MORPHOTEK, INC. ACQUIRES TUMOR TARGETING ASSETS …
- https://www.eisai.com/news/pdf/enews201131pdf.pdf
- platform from TransMolecular, Inc. (Headquarters: United States, Representative: Robert Radie, “TMI”), a biotechnology company headquartered in King …
MORPHOTEK, INC. ACQUIRES TUMOR TARGETING ASSETS FROM ...
- https://www.eisai.com/news/news201131.html
- Apr 05, 2011 · April 5, 2011. Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, “Eisai”) announced today that its U.S. subsidiary Morphotek, Inc. has acquired certain assets relating to a proprietary tumor targeting platform from TransMolecular, Inc. (Headquarters: United States, Representative: Robert Radie, “TMI”), a biotechnology company headquartered in King of Prussia, …
Jobs with TransMolecular, Inc. - BioSpace
- https://www.biospace.com/employer/515252/transmolecular-inc-/
- Jun 17, 2009 · TransMolecular, Inc. Reaches Special Protocol Agreement with FDA for an 131I-TM601 Phase 3 Trial in Newly Diagnosed Glioblastoma Multiforme Patients 12/2/2008 Radioactive Scorpion Venom Could Be Used To Fight Brain Cancer, University of Chicago Study; Dosing Began In TransMolecular, Inc.'s Phase 1/2 Clinical Trial Of 131I-TM601
Have you found Transmolecular Inc Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.